Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RYZ101 (Ac-225 DOTATATE) Opportunity beyond Gastroenteropancreatic Neuroendocrine Tumors: Preclinical Efficacy in Small-Cell Lung Cancer
Guangzhou Han, Eunmi Hwang, Fanching Lin, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 12, pp. 1434-1443
Open Access | Times Cited: 11

Showing 11 citing articles:

Peptide Binder to Glypican-3 as a Theranostic Agent for Hepatocellular Carcinoma
Fanching Lin, Renee Clift, Takeru Ehara, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. 4, pp. 586-592
Closed Access | Times Cited: 13
Theranostics in Lung Neuroendocrine Tumors
Indraja D. Dev, Ameya Puranik, Nikolaos A. Trikalinos, et al.
Seminars in Nuclear Medicine (2025)
Closed Access | Times Cited: 1
Significant response to [225Ac]Ac-DOTATATE therapy in a patient with small cell lung cancer
Murat Tuncel, Cem Türkan, Yavuz Eryilmaz, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Closed Access
Ac-225 radiochemistry through the lens of [225Ac]Ac-DOTA-TATE
Eline L. Hooijman, J. R. de Jong, Carolline M. Ntihabose, et al.
EJNMMI Radiopharmacy and Chemistry (2025) Vol. 10, Iss. 1
Open Access
Peptide receptor radionuclide therapy with somatostatin analogs beyond gastroenteropancreatic neuroendocrine tumors
Giulia Santo, Gianpaolo di Santo, Francesco Cicone, et al.
Journal of Neuroendocrinology (2025)
Open Access
PET- and CT-Based Imaging Criteria for Response Assessment of Gastroenteropancreatic Neuroendocrine Tumors Under Radiopharmaceutical Therapy
Friederike Herr, Cristina Mihaela Dascalescu, Matthias P. Fabritius, et al.
Journal of Nuclear Medicine (2025), pp. jnumed.124.268621-jnumed.124.268621
Closed Access
Intersection between lung cancer and neuroscience: opportunities and challenges
Xiang Xiao, Lingli Huang, Ming Li, et al.
Cancer Letters (2025), pp. 217701-217701
Closed Access
Small Cell Lung Cancer Neuronal Features and Their Implications for Tumor Progression, Metastasis, and Therapy
Griffin G. Hartmann, Julien Sage
Molecular Cancer Research (2024) Vol. 22, Iss. 9, pp. 787-795
Closed Access | Times Cited: 3
Theranostics with somatostatin receptor antagonists in SCLC: Correlation of 68Ga-SSO120 PET with immunohistochemistry and survival
Ilektra Antonia Mavroeidi, Anna Romanowicz, T. Haake, et al.
Theranostics (2024) Vol. 14, Iss. 14, pp. 5400-5412
Open Access | Times Cited: 2
Open-Flask Protocol for the Removal of Alloc Carbamate and Allyl Ester Protecting Groups. Application to In-solution and On-resin Peptide Synthesis
Patrick Napier, Nicole A. Bakas, Abhijit Bhat, et al.
The Journal of Organic Chemistry (2024)
Closed Access | Times Cited: 1
Preclinical safety and effectiveness of a long-acting somatostatin analogue [225Ac]Ac-EBTATE against small cell lung cancer and pancreatic neuroendocrine tumors
Fabrice Ngoh Njotu, Jessica Pougoue Ketchemen, Hanan Babeker, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024)
Closed Access
Page 1

Scroll to top